Stephan is a co-Founder and Chief Scientific Officer at Anokion, bringing more than 15 years of research expertise in the fields of immunology, protein engineering, and platform technologies to the company. He earned his B.Sc. in Chemical Engineering from the University of Texas at Austin and a Ph.D. in Bioengineering from the Swiss Federal Institute of Technology (EPFL) in Lausanne. During his thesis work, Stephan co-invented and developed the immune tolerance technology platform that inspired the founding of Anokion and its spin-off company Kanyos Bio. As a founding member of the executive leadership team, he has played a leading role in company creation, including raising equity capital, establishing transformative partnerships with pharmaceutical companies, and building teams and sites in the US and Switzerland. Stephan is an inventor of over 20 granted patents in the field of immune tolerance and continues to lead scientific innovation as head of Anokion's talented Research team.